| Name | Title | Contact Details |
|---|
Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.
American Leprosy Missions is a Greenville, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Toyon Associates is a Concord, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nobis Rehabilitation Partners brings together hospitals, developers, and investment partners to develop, operate, and manage inpatient rehabilitation facilities (“IRFs”) throughout the United States. With vast experience developing IRFs across the country, the Nobis team has refined both the physical design and operational functionality of the hospital; ultimately streamlining outcomes and profitability.
RRS Ohio is a company that offers effective outpatient, individualized addiction treatment and substance abuse disorder treatment. They provide a neutral safe space for individuals to heal, energize, and become aware of their inner strengths.